Bipolar  ||| S:0 E:8 ||| JJ
disorder  ||| S:8 E:17 ||| NN
in  ||| S:17 E:20 ||| IN
Enugu ||| S:20 E:25 ||| NNP
,  ||| S:25 E:27 ||| ,
South  ||| S:27 E:33 ||| NNP
East  ||| S:33 E:38 ||| NNP
Nigeria ||| S:38 E:45 ||| NNP
:  ||| S:45 E:47 ||| :
demographic  ||| S:47 E:59 ||| JJ
and  ||| S:59 E:63 ||| CC
diagnostic  ||| S:63 E:74 ||| JJ
characteristics  ||| S:74 E:90 ||| NNS
of  ||| S:90 E:93 ||| IN
patients  ||| S:93 E:102 ||| NNS
bipolar  ||| S:102 E:110 ||| JJ
disorder  ||| S:110 E:119 ||| NN
is  ||| S:119 E:122 ||| VBZ
a  ||| S:122 E:124 ||| DT
severe  ||| S:124 E:131 ||| JJ
mental  ||| S:131 E:138 ||| JJ
disorder  ||| S:138 E:147 ||| NN
that  ||| S:147 E:152 ||| WDT
has  ||| S:152 E:156 ||| VBZ
been  ||| S:156 E:161 ||| VBN
widely  ||| S:161 E:168 ||| RB
studied  ||| S:168 E:176 ||| VBN
in  ||| S:176 E:179 ||| IN
developed  ||| S:179 E:189 ||| JJ
countries ||| S:189 E:198 ||| NNS
.  ||| S:198 E:200 ||| .
Very  ||| S:200 E:205 ||| RB
few  ||| S:205 E:209 ||| JJ
studies  ||| S:209 E:217 ||| NNS
of  ||| S:217 E:220 ||| IN
this  ||| S:220 E:225 ||| DT
disorder  ||| S:225 E:234 ||| NN
exist  ||| S:234 E:240 ||| VBP
in  ||| S:240 E:243 ||| IN
developing  ||| S:243 E:254 ||| VBG
countries ||| S:254 E:263 ||| NNS
.  ||| S:263 E:265 ||| .
The  ||| S:265 E:269 ||| DT
objective  ||| S:269 E:279 ||| NN
of  ||| S:279 E:282 ||| IN
this  ||| S:282 E:287 ||| DT
study  ||| S:287 E:293 ||| NN
was  ||| S:293 E:297 ||| VBD
to  ||| S:297 E:300 ||| TO
describe  ||| S:300 E:309 ||| VB
the  ||| S:309 E:313 ||| DT
demographic  ||| S:313 E:325 ||| JJ
and  ||| S:325 E:329 ||| CC
diagnostic  ||| S:329 E:340 ||| JJ
characteristics  ||| S:340 E:356 ||| NNS
of  ||| S:356 E:359 ||| IN
bipolar  ||| S:359 E:367 ||| JJ
patients  ||| S:367 E:376 ||| NNS
in  ||| S:376 E:379 ||| IN
Enugu ||| S:379 E:384 ||| NNP
,  ||| S:384 E:386 ||| ,
South  ||| S:386 E:392 ||| NNP
East  ||| S:392 E:397 ||| NNP
Nigeria.  ||| S:397 E:406 ||| CD
the  ||| S:406 E:410 ||| DT
design  ||| S:410 E:417 ||| NN
of  ||| S:417 E:420 ||| IN
the  ||| S:420 E:424 ||| DT
study  ||| S:424 E:430 ||| NN
was  ||| S:430 E:434 ||| VBD
cross-sectional ||| S:434 E:449 ||| JJ
.  ||| S:449 E:451 ||| .
The  ||| S:451 E:455 ||| DT
study  ||| S:455 E:461 ||| NN
was  ||| S:461 E:465 ||| VBD
carried  ||| S:465 E:473 ||| VBN
out  ||| S:473 E:477 ||| RP
in  ||| S:477 E:480 ||| IN
Federal  ||| S:480 E:488 ||| NNP
Neuropsychiatric  ||| S:488 E:505 ||| NNP
Hospital  ||| S:505 E:514 ||| NNP
Enugu  ||| S:514 E:520 ||| NNP
( ||| S:520 E:521 ||| -LRB-
FNPHE ||| S:521 E:526 ||| NNP
)  ||| S:526 E:528 ||| -RRB-
and  ||| S:528 E:532 ||| CC
in  ||| S:532 E:535 ||| IN
a  ||| S:535 E:537 ||| DT
Private  ||| S:537 E:545 ||| NNP
Psychiatrist ||| S:545 E:557 ||| NNP
's  ||| S:557 E:560 ||| POS
Office  ||| S:560 E:567 ||| NNP
( ||| S:567 E:568 ||| -LRB-
PPO ||| S:568 E:571 ||| NNP
)  ||| S:571 E:573 ||| -RRB-
in  ||| S:573 E:576 ||| IN
Enugu ||| S:576 E:581 ||| NNP
,  ||| S:581 E:583 ||| ,
South  ||| S:583 E:589 ||| NNP
East  ||| S:589 E:594 ||| NNP
Nigeria.  ||| S:594 E:603 ||| CD
94  ||| S:603 E:606 ||| CD
patients  ||| S:606 E:615 ||| NNS
were  ||| S:615 E:620 ||| VBD
recruited  ||| S:620 E:630 ||| VBN
to  ||| S:630 E:633 ||| TO
take  ||| S:633 E:638 ||| VB
part  ||| S:638 E:643 ||| NN
in  ||| S:643 E:646 ||| IN
the  ||| S:646 E:650 ||| DT
study.  ||| S:650 E:657 ||| CD
49  ||| S:657 E:660 ||| CD
patients  ||| S:660 E:669 ||| NNS
were  ||| S:669 E:674 ||| VBD
included  ||| S:674 E:683 ||| VBN
from  ||| S:683 E:688 ||| IN
the  ||| S:688 E:692 ||| DT
FNPHE  ||| S:692 E:698 ||| NNP
and  ||| S:698 E:702 ||| CC
45  ||| S:702 E:705 ||| CD
patients  ||| S:705 E:714 ||| NNS
from  ||| S:714 E:719 ||| IN
the  ||| S:719 E:723 ||| DT
PPO ||| S:723 E:726 ||| NNP
.  ||| S:726 E:728 ||| .
The  ||| S:728 E:732 ||| DT
two  ||| S:732 E:736 ||| CD
groups  ||| S:736 E:743 ||| NNS
of  ||| S:743 E:746 ||| IN
patients  ||| S:746 E:755 ||| NNS
differed  ||| S:755 E:764 ||| VBP
only  ||| S:764 E:769 ||| RB
in  ||| S:769 E:772 ||| IN
terms  ||| S:772 E:778 ||| NNS
of  ||| S:778 E:781 ||| IN
mood  ||| S:781 E:786 ||| NN
at  ||| S:786 E:789 ||| IN
study  ||| S:789 E:795 ||| NN
entry ||| S:795 E:800 ||| NN
.  ||| S:800 E:802 ||| .
Patients  ||| S:802 E:811 ||| NNS
were  ||| S:811 E:816 ||| VBD
included  ||| S:816 E:825 ||| VBN
in  ||| S:825 E:828 ||| IN
the  ||| S:828 E:832 ||| DT
study  ||| S:832 E:838 ||| NN
if  ||| S:838 E:841 ||| IN
they  ||| S:841 E:846 ||| PRP
had  ||| S:846 E:850 ||| VBD
been  ||| S:850 E:855 ||| VBN
diagnosed  ||| S:855 E:865 ||| JJ
bipolar ||| S:865 E:872 ||| NN
,  ||| S:872 E:874 ||| ,
if  ||| S:874 E:877 ||| IN
they  ||| S:877 E:882 ||| PRP
were  ||| S:882 E:887 ||| VBD
attending  ||| S:887 E:897 ||| VBG
the  ||| S:897 E:901 ||| DT
FNPHE  ||| S:901 E:907 ||| NNP
as  ||| S:907 E:910 ||| IN
outpatients ||| S:910 E:921 ||| NN
,  ||| S:921 E:923 ||| ,
inpatients  ||| S:923 E:934 ||| NN
or  ||| S:934 E:937 ||| CC
were  ||| S:937 E:942 ||| VBD
receiving  ||| S:942 E:952 ||| VBG
emergency  ||| S:952 E:962 ||| NN
treatment  ||| S:962 E:972 ||| NN
or  ||| S:972 E:975 ||| CC
if  ||| S:975 E:978 ||| IN
they  ||| S:978 E:983 ||| PRP
were  ||| S:983 E:988 ||| VBD
attending  ||| S:988 E:998 ||| VBG
the  ||| S:998 E:1002 ||| DT
PPO  ||| S:1002 E:1006 ||| NNP
for  ||| S:1006 E:1010 ||| IN
follow-up  ||| S:1010 E:1020 ||| JJ
and  ||| S:1020 E:1024 ||| CC
if  ||| S:1024 E:1027 ||| IN
they  ||| S:1027 E:1032 ||| PRP
had  ||| S:1032 E:1036 ||| VBD
given  ||| S:1036 E:1042 ||| VBN
their  ||| S:1042 E:1048 ||| PRP$
consent  ||| S:1048 E:1056 ||| NN
to  ||| S:1056 E:1059 ||| TO
participate  ||| S:1059 E:1071 ||| VB
in  ||| S:1071 E:1074 ||| IN
the  ||| S:1074 E:1078 ||| DT
study ||| S:1078 E:1083 ||| NN
.  ||| S:1083 E:1085 ||| .
The  ||| S:1085 E:1089 ||| DT
patients  ||| S:1089 E:1098 ||| NNS
responded  ||| S:1098 E:1108 ||| VBD
to  ||| S:1108 E:1111 ||| TO
a  ||| S:1111 E:1113 ||| DT
structured  ||| S:1113 E:1124 ||| JJ
questionnaire  ||| S:1124 E:1138 ||| NN
used  ||| S:1138 E:1143 ||| VBN
to  ||| S:1143 E:1146 ||| TO
elicit  ||| S:1146 E:1153 ||| VB
demographic  ||| S:1153 E:1165 ||| JJ
and  ||| S:1165 E:1169 ||| CC
diagnostic  ||| S:1169 E:1180 ||| JJ
characteristics ||| S:1180 E:1195 ||| NNS
.  ||| S:1195 E:1197 ||| .
This  ||| S:1197 E:1202 ||| DT
questionnaire  ||| S:1202 E:1216 ||| NN
was  ||| S:1216 E:1220 ||| VBD
administered  ||| S:1220 E:1233 ||| VBN
by  ||| S:1233 E:1236 ||| IN
one  ||| S:1236 E:1240 ||| CD
of  ||| S:1240 E:1243 ||| IN
the  ||| S:1243 E:1247 ||| DT
authors  ||| S:1247 E:1255 ||| NNS
( ||| S:1255 E:1256 ||| -LRB-
EJ ||| S:1256 E:1258 ||| NNP
) ||| S:1258 E:1259 ||| -RRB-
.  ||| S:1259 E:1261 ||| .
Each  ||| S:1261 E:1266 ||| DT
patient  ||| S:1266 E:1274 ||| NN
was  ||| S:1274 E:1278 ||| VBD
also  ||| S:1278 E:1283 ||| RB
interviewed  ||| S:1283 E:1295 ||| VBN
with  ||| S:1295 E:1300 ||| IN
the  ||| S:1300 E:1304 ||| DT
Mini  ||| S:1304 E:1309 ||| NNP
International  ||| S:1309 E:1323 ||| NNP
Neuropsychiatric  ||| S:1323 E:1340 ||| NNP
Interview  ||| S:1340 E:1350 ||| NNP
( ||| S:1350 E:1351 ||| -LRB-
MINI ||| S:1351 E:1355 ||| NNP
)  ||| S:1355 E:1357 ||| -RRB-
for  ||| S:1357 E:1361 ||| IN
Bipolar  ||| S:1361 E:1369 ||| NNP
Disorder  ||| S:1369 E:1378 ||| NNP
Studies  ||| S:1378 E:1386 ||| NNPS
version  ||| S:1386 E:1394 ||| NN
5.0.0 ||| S:1394 E:1399 ||| NN
.  ||| S:1399 E:1401 ||| .
This  ||| S:1401 E:1406 ||| DT
MINI  ||| S:1406 E:1411 ||| NNP
assessment  ||| S:1411 E:1422 ||| NN
was  ||| S:1422 E:1426 ||| VBD
done  ||| S:1426 E:1431 ||| VBN
by  ||| S:1431 E:1434 ||| IN
( ||| S:1434 E:1435 ||| -LRB-
MO ||| S:1435 E:1437 ||| NNP
) ||| S:1437 E:1438 ||| -RRB-
.  ||| S:1438 E:1440 ||| .
All  ||| S:1440 E:1444 ||| PDT
the  ||| S:1444 E:1448 ||| DT
data  ||| S:1448 E:1453 ||| NNS
were  ||| S:1453 E:1458 ||| VBD
collected  ||| S:1458 E:1468 ||| VBN
in  ||| S:1468 E:1471 ||| IN
a  ||| S:1471 E:1473 ||| DT
specially  ||| S:1473 E:1483 ||| RB
prepared  ||| S:1483 E:1492 ||| JJ
data  ||| S:1492 E:1497 ||| NN
collection  ||| S:1497 E:1508 ||| NN
form ||| S:1508 E:1512 ||| NN
.  ||| S:1512 E:1514 ||| .
The  ||| S:1514 E:1518 ||| DT
demographic  ||| S:1518 E:1530 ||| JJ
factors  ||| S:1530 E:1538 ||| NNS
reported  ||| S:1538 E:1547 ||| VBD
on  ||| S:1547 E:1550 ||| IN
included  ||| S:1550 E:1559 ||| VBN
gender ||| S:1559 E:1565 ||| NN
,  ||| S:1565 E:1567 ||| ,
age ||| S:1567 E:1570 ||| NN
,  ||| S:1570 E:1572 ||| ,
marital  ||| S:1572 E:1580 ||| JJ
status ||| S:1580 E:1586 ||| NN
,  ||| S:1586 E:1588 ||| ,
level  ||| S:1588 E:1594 ||| NN
of  ||| S:1594 E:1597 ||| IN
education  ||| S:1597 E:1607 ||| NN
and  ||| S:1607 E:1611 ||| CC
employment  ||| S:1611 E:1622 ||| NN
status ||| S:1622 E:1628 ||| NN
.  ||| S:1628 E:1630 ||| .
The  ||| S:1630 E:1634 ||| DT
reported  ||| S:1634 E:1643 ||| VBN
diagnostic  ||| S:1643 E:1654 ||| JJ
and  ||| S:1654 E:1658 ||| CC
illness  ||| S:1658 E:1666 ||| NN
characteristics  ||| S:1666 E:1682 ||| NNS
included  ||| S:1682 E:1691 ||| VBD
age  ||| S:1691 E:1695 ||| NN
at  ||| S:1695 E:1698 ||| IN
onset  ||| S:1698 E:1704 ||| NN
of  ||| S:1704 E:1707 ||| IN
illness ||| S:1707 E:1714 ||| NN
,  ||| S:1714 E:1716 ||| ,
mood  ||| S:1716 E:1721 ||| NN
at  ||| S:1721 E:1724 ||| IN
study  ||| S:1724 E:1730 ||| NN
entry  ||| S:1730 E:1736 ||| NN
and  ||| S:1736 E:1740 ||| CC
mood  ||| S:1740 E:1745 ||| NN
at  ||| S:1745 E:1748 ||| IN
onset  ||| S:1748 E:1754 ||| NN
of  ||| S:1754 E:1757 ||| IN
illness ||| S:1757 E:1764 ||| NN
.  ||| S:1764 E:1766 ||| .
The  ||| S:1766 E:1770 ||| DT
data  ||| S:1770 E:1775 ||| NNS
were  ||| S:1775 E:1780 ||| VBD
analyzed  ||| S:1780 E:1789 ||| VBN
using  ||| S:1789 E:1795 ||| VBG
SPSS  ||| S:1795 E:1800 ||| NNP
version  ||| S:1800 E:1808 ||| NN
11.5 ||| S:1808 E:1812 ||| CD
.  ||| S:1812 E:1814 ||| .
Frequencies  ||| S:1814 E:1826 ||| NNP
were  ||| S:1826 E:1831 ||| VBD
run  ||| S:1831 E:1835 ||| VBN
on  ||| S:1835 E:1838 ||| IN
demographic  ||| S:1838 E:1850 ||| JJ
characteristics  ||| S:1850 E:1866 ||| NNS
while  ||| S:1866 E:1872 ||| IN
means  ||| S:1872 E:1878 ||| NNS
and  ||| S:1878 E:1882 ||| CC
standard  ||| S:1882 E:1891 ||| JJ
deviations  ||| S:1891 E:1902 ||| NNS
were  ||| S:1902 E:1907 ||| VBD
calculated  ||| S:1907 E:1918 ||| VBN
for  ||| S:1918 E:1922 ||| IN
continuous  ||| S:1922 E:1933 ||| JJ
variables ||| S:1933 E:1942 ||| NNS
.  ||| S:1942 E:1944 ||| .
The  ||| S:1944 E:1948 ||| DT
study  ||| S:1948 E:1954 ||| NN
was  ||| S:1954 E:1958 ||| VBD
approved  ||| S:1958 E:1967 ||| VBN
by  ||| S:1967 E:1970 ||| IN
the  ||| S:1970 E:1974 ||| DT
Research  ||| S:1974 E:1983 ||| NNP
Ethics  ||| S:1983 E:1990 ||| NNP
Committee  ||| S:1990 E:2000 ||| NNP
of  ||| S:2000 E:2003 ||| IN
the  ||| S:2003 E:2007 ||| DT
FNPHE.  ||| S:2007 E:2014 ||| CD
the  ||| S:2014 E:2018 ||| DT
majority  ||| S:2018 E:2027 ||| NN
of  ||| S:2027 E:2030 ||| IN
the  ||| S:2030 E:2034 ||| DT
sample  ||| S:2034 E:2041 ||| NN
( ||| S:2041 E:2042 ||| -LRB-
68.1 ||| S:2042 E:2046 ||| CD
% ||| S:2046 E:2047 ||| NN
)  ||| S:2047 E:2049 ||| -RRB-
met  ||| S:2049 E:2053 ||| VBD
the  ||| S:2053 E:2057 ||| DT
criteria  ||| S:2057 E:2066 ||| NNS
for  ||| S:2066 E:2070 ||| IN
bipolar  ||| S:2070 E:2078 ||| VBG
I  ||| S:2078 E:2080 ||| PRP
disorder ||| S:2080 E:2088 ||| VBD
.  ||| S:2088 E:2090 ||| .
The  ||| S:2090 E:2094 ||| DT
mean  ||| S:2094 E:2099 ||| JJ
age  ||| S:2099 E:2103 ||| NN
of  ||| S:2103 E:2106 ||| IN
patients  ||| S:2106 E:2115 ||| NNS
was  ||| S:2115 E:2119 ||| VBD
33.17  ||| S:2119 E:2125 ||| CD
( ||| S:2125 E:2126 ||| -LRB-
SD  ||| S:2126 E:2129 ||| NNP
=  ||| S:2129 E:2131 ||| SYM
11.87 ||| S:2131 E:2136 ||| CD
)  ||| S:2136 E:2138 ||| -RRB-
years  ||| S:2138 E:2144 ||| NNS
and  ||| S:2144 E:2148 ||| CC
mean  ||| S:2148 E:2153 ||| JJ
duration  ||| S:2153 E:2162 ||| NN
of  ||| S:2162 E:2165 ||| IN
bipolar  ||| S:2165 E:2173 ||| JJ
illness  ||| S:2173 E:2181 ||| NN
was  ||| S:2181 E:2185 ||| VBD
9.6  ||| S:2185 E:2189 ||| CD
( ||| S:2189 E:2190 ||| -LRB-
SD  ||| S:2190 E:2193 ||| NNP
=  ||| S:2193 E:2195 ||| SYM
8.9 ||| S:2195 E:2198 ||| CD
)  ||| S:2198 E:2200 ||| -RRB-
years ||| S:2200 E:2205 ||| NNS
.  ||| S:2205 E:2207 ||| .
Among  ||| S:2207 E:2213 ||| IN
the  ||| S:2213 E:2217 ||| DT
94  ||| S:2217 E:2220 ||| CD
patients ||| S:2220 E:2228 ||| NNS
,  ||| S:2228 E:2230 ||| ,
58.8 ||| S:2230 E:2234 ||| CD
%  ||| S:2234 E:2236 ||| NN
were  ||| S:2236 E:2241 ||| VBD
males ||| S:2241 E:2246 ||| NNS
.  ||| S:2246 E:2248 ||| .
The  ||| S:2248 E:2252 ||| DT
mean  ||| S:2252 E:2257 ||| JJ
age  ||| S:2257 E:2261 ||| NN
at  ||| S:2261 E:2264 ||| IN
onset  ||| S:2264 E:2270 ||| NN
of  ||| S:2270 E:2273 ||| IN
illness  ||| S:2273 E:2281 ||| NN
for  ||| S:2281 E:2285 ||| IN
the  ||| S:2285 E:2289 ||| DT
whole  ||| S:2289 E:2295 ||| JJ
group  ||| S:2295 E:2301 ||| NN
was  ||| S:2301 E:2305 ||| VBD
22.9  ||| S:2305 E:2310 ||| CD
( ||| S:2310 E:2311 ||| -LRB-
SD  ||| S:2311 E:2314 ||| NNP
=  ||| S:2314 E:2316 ||| SYM
8.3 ||| S:2316 E:2319 ||| CD
)  ||| S:2319 E:2321 ||| -RRB-
years.  ||| S:2321 E:2328 ||| VBZ
the  ||| S:2328 E:2332 ||| DT
current  ||| S:2332 E:2340 ||| JJ
report  ||| S:2340 E:2347 ||| NN
is  ||| S:2347 E:2350 ||| VBZ
probably  ||| S:2350 E:2359 ||| RB
the  ||| S:2359 E:2363 ||| DT
first  ||| S:2363 E:2369 ||| JJ
on  ||| S:2369 E:2372 ||| IN
bipolar  ||| S:2372 E:2380 ||| JJ
disorder  ||| S:2380 E:2389 ||| NN
in  ||| S:2389 E:2392 ||| IN
this  ||| S:2392 E:2397 ||| DT
part  ||| S:2397 E:2402 ||| NN
of  ||| S:2402 E:2405 ||| IN
Africa ||| S:2405 E:2411 ||| NNP
.  ||| S:2411 E:2413 ||| .
It  ||| S:2413 E:2416 ||| PRP
will  ||| S:2416 E:2421 ||| MD
serve  ||| S:2421 E:2427 ||| VB
as  ||| S:2427 E:2430 ||| IN
an  ||| S:2430 E:2433 ||| DT
impetus  ||| S:2433 E:2441 ||| NN
to  ||| S:2441 E:2444 ||| TO
conduct  ||| S:2444 E:2452 ||| VB
more  ||| S:2452 E:2457 ||| JJR
research  ||| S:2457 E:2466 ||| NN
on  ||| S:2466 E:2469 ||| IN
the  ||| S:2469 E:2473 ||| DT
topic  ||| S:2473 E:2479 ||| NN
especially  ||| S:2479 E:2490 ||| RB
since  ||| S:2490 E:2496 ||| IN
some  ||| S:2496 E:2501 ||| DT
important  ||| S:2501 E:2511 ||| JJ
findings  ||| S:2511 E:2520 ||| NNS
are  ||| S:2520 E:2524 ||| VBP
similar  ||| S:2524 E:2532 ||| JJ
to  ||| S:2532 E:2535 ||| TO
what  ||| S:2535 E:2540 ||| WP
had  ||| S:2540 E:2544 ||| VBD
been  ||| S:2544 E:2549 ||| VBN
recorded  ||| S:2549 E:2558 ||| VBN
from  ||| S:2558 E:2563 ||| IN
both  ||| S:2563 E:2568 ||| DT
developed  ||| S:2568 E:2578 ||| VBN
and  ||| S:2578 E:2582 ||| CC
developing  ||| S:2582 E:2593 ||| VBG
countries ||| S:2593 E:2602 ||| NNS
.  ||| S:2602 E:2604 ||| .
